Delivery Order 36F79724D0159-15B50926F00000100
Award Date 9/1/26
Potential Completion Date 9/30/26
Potential Value $62K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Titusville, Hopewell Township, NJ 08560, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Federal Correctional Institution Fort Worth awarded a delivery order valued at $61,988.37 to Actelion Pharmaceuticals US, Inc. for pharmaceutical products Uptravi and Opsumit, effective July 1 through July 31, 2026. This is a firm fixed-price delivery order with no small business set-aside designation. The award is issued under Actelion's parent Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), a multiple-award schedule valued at $219.1 million with a performance...
- The Federal Correctional Institution Fort Worth awarded a delivery order valued at approximately $62K to Actelion Pharmaceuticals US, Inc. for pharmaceutical products Uptravi (selexipag) and Opsumit through a Firm Fixed Price contract with a completion date of May 31, 2026. This delivery order is a child contract issued under the parent Federal Supply Schedule 61-IB (Pharmaceuticals and Drugs) contract, which provides a streamlined procurement vehicle for federal agencies to order pre-negotiated...
- The Federal Correctional Institution Fort Worth awarded a delivery order to Actelion Pharmaceuticals US, Inc. on April 1, 2026, with a ceiling value of $61,988.37 and completion date of April 30, 2026. This firm fixed-price delivery order falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, a multiple-award schedule valued at $219.1 million with a performance period extending through July 31, 2029. The award carries no set-aside designation, and the ordering is...
- Actelion Pharmaceuticals US, Inc. has been awarded a delivery order valued at approximately $62k by the Federal Correctional Institution Fort Worth for the supply of Uptravi (selexipag) and Opsumit pharmaceutical products, with a completion date of June 30, 2026. This award is a firm fixed-price delivery order issued without a set-aside designation and represents part of the company's ongoing pharmaceutical supply relationship with the Federal Bureau of Prisons. The products will be delivered to...
- Actelion Pharmaceuticals US, Inc. has been awarded a delivery order valued at $61,988.37 under the FY26 Pharmacy March procurement, with an ultimate completion date of March 31, 2026. This firm fixed-price delivery order was issued by the Federal Correctional Institution Fort Worth on March 1, 2026, with no small business set-aside designation. The contract represents a continuation of pharmaceutical supply services under Actelion's existing Federal Supply Schedule contract (FSS-61-IB) for...
- The Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth awarded a $215,044.95 delivery order to Actelion Pharmaceuticals US, Inc. for the provision of medication for inmate use. This order was placed against Actelion's Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs, which allows federal agencies to procure needed prescription medications at pre-negotiated pricing. Actelion Pharmaceuticals is a for-profit organization that manufactures...
- Actelion Pharmaceuticals US, Inc. received a $61,988.37 firm fixed-price delivery order from the Federal Medical Center Carswell, a civilian facility within the Department of Justice's Federal Bureau of Prisons system. Issued on January 31, 2026, with completion targeted for the same date, this delivery order represents a single procurement action under Actelion's broader Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The order was placed without a small business...
- This federal contract award, valued at $72,516.33, was issued by the Federal Medical Center Carswell, a civilian agency, to the prime contractor Actelion Pharmaceuticals US, Inc., a large for-profit pharmaceutical manufacturer. The contract is a delivery order under Actelion's existing Federal Supply Schedule (FSS-61-IB) contract with the Department of Veterans Affairs (VA), which has a total potential value of $219,108,390 over the period of August 2024 to July 2029. The contract provides for...
- Actelion Pharmaceuticals US, Inc. has been awarded a $19,535.58 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) managed by the General Services Administration. The order is for 1,600 microgram bottles of Uptravi to be provided to the Federal Bureau of Prisons' Federal Medical Center in Carswell, Texas by February 2029. The delivery order was issued without a set-aside designation by the Department of Justice Bureau of Prisons on February 2, 2024. Actelion...
- Actelion Pharmaceuticals US, Inc. has been awarded a $19,535.58 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) managed by the General Services Administration. The order is for 1,600 microgram bottles of Uptravi to be provided to the Federal Bureau of Prisons' Federal Medical Center in Carswell, Texas by February 2029. No set-aside designation was used for this award placed under the prime contractor's existing $105 million, five-year Pharmaceuticals...